In Jan 1ST, 2001 GenMont was established by the internationally esteemed clinical/experimental immunologist Dr. Hsu, Ching-shiang, with now a capital of NTD 300 millio around USD 8.8 millio. Currently our proprietary technologies have being patented worldwide and the business has being extended to new drug discovery as well as functional food development. We are now intended to be a market overt into Taiwan stock market in late 2003.
*Executive summary
GenMont is engaged in the development of immune and auto-immune therapeutics/functional foods and are evolving toward becoming an integrated biotechnology business. GenMont are striving to reach a dominant position in functional L.A.B.(Lactic Acid Bacteria)products of safety and effectiveness. GenMont is further extending R&D collaborations/strategic alliances with major academic institutes and bio-pharmaceutical/food companies worldwide.